feed,title,long_url,short_url
Investors,Biogen Tops Second-Quarter Estimates With Alzheimer's Drug Not Yet Profitable,https://www.investors.com/news/technology/biogen-stock-alzheimers-drug-not-yet-profitable-as-company-tops-earnings-views/,https://da.gd/8F9Sbb
